Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 8-K Event Material agreement · Unregistered share sale
  2. 8-K Event Other events
  3. S-3 Offering Registration Statement
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Other events
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 8-K Event Other events
  14. 8-K Event Shareholder rights changed
  15. 8-K Event Other events
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 4 of 21 · 412 filings